{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:16:04Z","timestamp":1778256964241,"version":"3.51.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clindermatol.2020.06.012","type":"journal-article","created":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T01:28:23Z","timestamp":1593912503000},"page":"648-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neutrophilic drug reactions"],"prefix":"10.1016","volume":"38","author":[{"given":"Alexandra J.","family":"Coromilas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Gallitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.06.012_bb0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","article-title":"Acute generalized exanthematous pustulosis. Analysis of 63 cases","volume":"127","author":"Roujeau","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","article-title":"Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases","volume":"80","author":"Baker","year":"1968","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0020","first-page":"37","article-title":"Acute generalized exanthematic pustuloses (four cases)","volume":"107","author":"Beylot","year":"1980","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustulosis (AGEP)\u2014results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/ijd.13434","article-title":"Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013","volume":"56","author":"Alniemi","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0035","doi-asserted-by":"crossref","first-page":"260928","DOI":"10.1155\/2015\/260928","article-title":"Five-year retrospective review of acute generalized exanthematous pustulosis","volume":"2015","author":"Thienvibul","year":"2015","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0040","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI12118","article-title":"T-cell involvement in drug-induced acute generalized exanthematous pustulosis","volume":"107","author":"Britschgi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0045","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0002-9440(10)64486-0","article-title":"Acute generalized exanthematous pustulosis role of cytotoxic T cells in pustule formation","volume":"161","author":"Schmid","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0050","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/jid.2013.44","article-title":"Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis","volume":"133","author":"Navarini","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)- a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jdcr.2018.03.017","article-title":"Acute localized exanthematous pustulosis (ALEP) caused by lamotrigine","volume":"4","author":"Hopkins","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0065","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.12502","article-title":"Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients","volume":"169","author":"Hotz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40560-015-0114-3","article-title":"Vancomycin-induced acute generalized exanthematous pustulosis (AGEP) masquerading septic shock-an unusual presentation of a rare disease","volume":"10","author":"Mawri","year":"2015","journal-title":"J Intensive Care"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0075","article-title":"An illusion of septic shock: acute generalised exanthematous pustulosis with multiorgan dysfunction","volume":"2","author":"Jakkidi","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2559.1993.tb00178.x","article-title":"Pustular drug eruptions: a histopathological spectrum","volume":"22","author":"Burrows","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2010.09967.x","article-title":"The spectrum of histopathologic features in acute generalized exanthematous pustulosis: a study of 102 cases","volume":"163","author":"Halevy","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ACI.0b013e32833aa54d","article-title":"Patch testing in drug allergy","volume":"10","author":"Friedmann","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.139.9.1181","article-title":"A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis","volume":"139","author":"Mashiah","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0100","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bjd.13540","article-title":"Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre","volume":"172","author":"Ingen-Housz-Oro","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet\u2019s syndrome\u2014a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0110","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00431-010-1201-z","article-title":"EPONYM. Sweet syndrome","volume":"169","author":"Kim","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0115","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0190-9622(98)70266-X","article-title":"Sweet\u2019s syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines?","volume":"39","author":"Giasuddin","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.140.5.570","article-title":"Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction","volume":"140","author":"Kawakami","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0125","series-title":"Dermatology","first-page":"379","article-title":"Neutrophilic dermatoses","author":"Moschella","year":"2008"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0130","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1067\/mjd.2000.109286","article-title":"Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited","volume":"43","author":"Galaria","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0135","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-4632.2012.05714.x","article-title":"Neutrophilic dermatosis of the dorsal hands during thalidomide treatment","volume":"53","author":"Mathieu","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0140","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/archderm.142.8.1070-b","article-title":"Neutrophilic dermatosis (Sweet syndrome) of the hands associated with lenalidomide","volume":"142","author":"Hoverson","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.survophthal.2008.02.006","article-title":"Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature","volume":"53","author":"Gottlieb","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.clinimag.2012.08.004","article-title":"Radiology-pathology conference: neutrophilic fasciitis and panniculitis of the feet (Sweet\u2019s syndrome)","volume":"37","author":"Stubbs","year":"2013","journal-title":"Clin Imaging"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0155","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.annder.2007.11.030","article-title":"Lethal pulmonary involvement of neutrophilic dermatosis following erythropoietin therapy","volume":"135","author":"Gaspar","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000372-198911020-00001","article-title":"Acute febrile neutrophilic dermatosis. A histopathological study of 37 patients and a review of the literature","volume":"11","author":"Jordaan","year":"1989","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jcp.40.2.175","article-title":"Sweet\u2019s syndrome: histological and immunohistochemical study of 15 cases","volume":"40","author":"Going","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0170","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0190-9622(96)90080-8","article-title":"Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet\u2019s syndrome","volume":"34","author":"Walker","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaad.2010.04.041","article-title":"The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome","volume":"65","author":"Bidinger","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0180","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/014107688507801216","article-title":"Profound circulatory collapse due to azathioprine","volume":"78","author":"Major","year":"1985","journal-title":"J R Soc Med"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.283.6295.823-a","article-title":"Azathioprine-induced shock","volume":"283","author":"Cunningham","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0190","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jamadermatol.2013.137","article-title":"Neutrophilic dermatosis after azathioprine exposure","volume":"149","author":"Cyrus","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00128071-200203020-00005","article-title":"Sweet\u2019s syndrome: a review of current treatment options","volume":"3","author":"Cohen","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0200","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jaad.2013.11.022","article-title":"Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma","volume":"70","author":"Kyllo","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0205","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.annder.2008.10.039","article-title":"Bortezomib-induced eruption: Sweet syndrome? Two case reports","volume":"136","author":"Thuillier","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2133.1999.02747.x","article-title":"Colchicine for Sweet\u2019s syndrome. A study of 20 cases","volume":"140","author":"Maillard","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0215","first-page":"737","article-title":"Dapsone in Sweet syndrome","volume":"29","author":"el Sherif","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0190-9622(83)70110-6","article-title":"Potassium iodide in erythema nodosum and other erythematous dermatoses","volume":"9","author":"Hiorio","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2340\/00015555-1990","article-title":"Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark","volume":"95","author":"Lings","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0230","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0235","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0250","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0245","article-title":"Cephalosporin-induced linear IgA dermatosis in a child: case report and literature review","volume":"32","author":"Sarikaya Solak","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0255","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0002-9440(10)64772-4","article-title":"The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases","volume":"156","author":"Schumann","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0260","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jid.2017.12.035","article-title":"Vancomycin mediates IgA autoreactivity in drug-induced linear IgA bullous dermatosis","volume":"138","author":"Yamagami","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ced.13030","article-title":"Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap","volume":"42","author":"Adler","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000353584","article-title":"Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature","volume":"227","author":"Kakar","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0275","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.1917.04270060103010","article-title":"A case of bromoderma, or bromo-iododerma","volume":"LXVIII","author":"Lane","year":"1917","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0280","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/bjd.12852","article-title":"Acute iododerma secondary to iodinated contrast media","volume":"170","author":"Young","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0190-9622(90)70057-O","article-title":"Vegetating iododerma with underlying systemic diseases: report of three cases","volume":"22","author":"Soria","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archderm.1934.01460100047004","article-title":"Iodized table salt as an etiologic factor in iododerma","volume":"29","author":"Bechet","year":"1934","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0295","first-page":"260","article-title":"Amiodarone induced iododerma treated by cyclosporine","volume":"124","author":"Ricci","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0300","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajd.12284","article-title":"Iododerma in pregnancy secondary to iodinated multivitamins","volume":"56","author":"Torkamani","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/thy.2009.0467","article-title":"Thyroid protection gone awry: iododerma following potassium iodide administration prior to metaiodobenzylguanidine scintigraphy","volume":"21","author":"Guerrero","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/15569527.2013.780181","article-title":"Iododerma following topical povidone-iodine application","volume":"32","author":"Aliagaoglu","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0315","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamadermatol.2013.4156","article-title":"Vegetative plaques and hemorrhagic pustules. Iododerma","volume":"149","author":"Stavert","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000018134","article-title":"Vegetating iododerma with fatal outcome","volume":"198","author":"Miranda-Romero","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000249474","article-title":"Vegetating iodides after an intravenous pyelogram","volume":"171","author":"Lauret","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0330","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archderm.1982.01650160053024","article-title":"Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy","volume":"118","author":"Harrist","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0738-081X(99)00123-6","article-title":"Neutrophilic eccrine hidradenitis","volume":"18","author":"Bachmeyer","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0340","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archderm.1986.01660190087022","article-title":"Neutrophilic eccrine hidradenitis associated with Hodgkin\u2019s disease and chemotherapy. A case report","volume":"122","author":"Beutner","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0345","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0190-9622(96)90092-4","article-title":"Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis","volume":"35","author":"Shear","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1525-1470.1989.tb00264.x","article-title":"Neutrophilic eccrine hidradenitis: a case report and review of the literature","volume":"6","author":"Bailey","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0355","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0560.1987.tb00499.x","article-title":"Neutrophilic eccrine hidradenitis associated with induction chemotherapy","volume":"14","author":"Fitzpatrick","year":"1987","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000372-199002000-00001","article-title":"Syringosquamous metaplasia. A distinctive eruption in patients receiving chemotherapy","volume":"12","author":"Bhawan","year":"1990","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0365","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mpo.2950160513","article-title":"Chemotherapy-associated eccrine hidradenitis: neutrophilic eccrine hidradenitis reevaluated: the role of neutrophilic infiltration","volume":"16","author":"Greenbaum","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0370","first-page":"233","article-title":"Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs","volume":"39","author":"Burg","year":"1988","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0375","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1097-0142(19881215)62:12<2532::AID-CNCR2820621214>3.0.CO;2-D","article-title":"Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent","volume":"62","author":"Scallan","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0380","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/15569527.2011.627077","article-title":"Neutrophilic eccrine hidradenitis induced by cetuximab","volume":"31","author":"Turan","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0385","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/bjd.15259","article-title":"Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event","volume":"176","author":"Herms","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0390","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ccr3.1932","article-title":"Neutrophilic eccrine hidradenitis secondary to pegfilgrastim in a patient with synovial sarcoma","volume":"7","author":"Puar","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0395","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0190-9622(08)80707-4","article-title":"Neutrophilic eccrine hidradenitis in HIV-infected patients. Armed Forces Retrovirus Research Group","volume":"23","author":"Smith","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0400","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/QAD.0b013e328351f64b","article-title":"Neutrophilic eccrine hidradenitis in an HIV-1-infected patient","volume":"26","author":"Rouanet","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0405","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0253-7613.106445","article-title":"Neutrophilic eccrine hidradenitis: a new culprit-carbamazepine","volume":"45","author":"Bhanu","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0410","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1191\/0961203303lu420cr","article-title":"Neutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient: a complication of cyclophosphamide","volume":"12","author":"Lienesch","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0415","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000334737","article-title":"Therapy-resistant, spontaneously remitting generalized neutrophilic eccrine hidradenitis in a healthy patient decreases the expression of dermcidin in affected eccrine glands","volume":"3","author":"Kambayashi","year":"2011","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0420","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s001050050654","article-title":"Eccrine hidradenitis. Case report and review of the literature","volume":"48","author":"Okcu","year":"1997","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0425","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2133.1998.02389.x","article-title":"Neutrophilic eccrine hidradenitis induced by granulocyte colony-stimulating factor","volume":"139","author":"Bachmeyer","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0430","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2133.1992.tb14854.x","article-title":"Recurrent neutrophilic eccrine hidradenitis","volume":"127","author":"Bernstein","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0435","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0755-4982(06)74837-0","article-title":"Adult idiopathic neutrophilic eccrine hidradenitis treated with colchicine","volume":"35","author":"Belot","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0440","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archdermatol.2011.2842","article-title":"Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management","volume":"148","author":"Zimmer","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0445","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/jamaoncol.2015.0457","article-title":"Panniculitis in patients undergoing treatment with the Bruton tyrosine kinase inhibitor ibrutinib for lymphoid leukemias","volume":"1","author":"Fabbro","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0450","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jdcr.2017.01.027","article-title":"Lower extremity ecchymotic nodules in a patient being treated with ibrutinib for chronic lymphocytic leukemia","volume":"3","author":"Hammel","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0455","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/DAD.0000000000000023","article-title":"Panniculitis in patients treated with BRAF inhibitors: a case series","volume":"36","author":"Choy","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0460","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/DAD.0000000000000528","article-title":"Vemurafenib-induced neutrophilic panniculitis: a new case and review of the literature","volume":"38","author":"Vazquez-Osorio","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0465","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/jdv.13039","article-title":"Erythema nodosum-like lesions during BRAF inhibitor therapy: report on 16 new cases and review of the literature","volume":"29","author":"Mossner","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0470","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/DAD.0000000000000980","article-title":"Self-limiting ibrutinib-induced neutrophilic panniculitis","volume":"40","author":"Stewart","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0475","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1684\/ejd.2013.1991","article-title":"Vemurafenib-induced panniculitis","volume":"23","author":"Villani","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0480","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/DAD.0000000000000441","article-title":"Cutaneous, purpuric painful nodules upon addition of ibrutinib to RCVP therapy in a CLL patient: a distinctive reaction pattern reflecting iatrogenic Th2 to Th1 milieu reversal","volume":"38","author":"Mulvey","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0485","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0490","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0495","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40257-017-0308-7","article-title":"Drug-induced pyoderma gangrenosum: a review","volume":"19","author":"Wang","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0500","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jdcr.2018.09.001","article-title":"Vulvovaginal pyoderma gangrenosum in association with rituximab","volume":"4","author":"Maloney","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0505","first-page":"638","article-title":"Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity","volume":"56","author":"Lood","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0510","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1468-3083.2006.01684.x","article-title":"Neutrophilic eccrine hidradenitis to acetaminophen","volume":"20","author":"Sayed","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0515","first-page":"403","article-title":"Neutrophilic eccrine hidradenitis in the absence of an underlying malignancy","volume":"41","author":"Kuttner","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.06.012_bb0520","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/postgradmedj-2019-136426","article-title":"Ticagrelor induced neutrophilic eccrine hidradenitis: a unique adverse effect of a new antiplatelet drug","volume":"95","author":"Bishnoi","year":"2019","journal-title":"Postgrad Med J"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:21Z","timestamp":1760033781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0738081X20301450"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic drug reactions","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}